SymThera ^{For Profit}

Symthera is a biopharmaceutical company that focuses on developing treatments for metastatic cancer. They have developed a proprietary approach to identify consensus amino acid sequences shared by, or unique to disease-associated proteins to validate disease-related targets and simultaneously identify drug leads that impact that network. Symthera's drug leads, biological peptides, address the immediate shortcomings of existing medication in the following ways: Protein derivatives - Low toxicity natural products - High specificity therapeutics - Minimal side effects - Immune modulators - Inducers of immune tolerance. The company has offices in Toronto, Canada, Ness-Ziona, Israel, and Walnut Creek, USA. Contact_info: - Email: info@symthera.com- Phone: +1.416.455.6233